Association between ABO Blood Types and the Risk of Gestational Diabetes Mellitus: A Prospective Cohort Study.
- Author:
Shuang Hua XIE
1
;
Shuang Ying LI
1
;
Shao Fei SU
1
;
En Jie ZHANG
1
;
Shen GAO
1
;
Yue ZHANG
2
;
Jian Hui LIU
1
;
Min Hui HU
1
;
Rui Xia LIU
1
;
Wen Tao YUE
2
;
Cheng Hong YIN
3
Author Information
- Publication Type:Journal Article
- Keywords: ABO blood type phenotype; Cohort study; Gestational diabetes mellitus; Risk factors
- MeSH: Humans; Female; Pregnancy; Diabetes, Gestational/etiology*; ABO Blood-Group System; Adult; Prospective Studies; Risk Factors; Young Adult
- From: Biomedical and Environmental Sciences 2025;38(6):678-692
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To investigate the association between ABO blood types and gestational diabetes mellitus (GDM) risk.
METHODS:A prospective birth cohort study was conducted. ABO blood types were determined using the slide method. GDM diagnosis was based on a 75-g, 2-h oral glucose tolerance test (OGTT) according to the criteria of the International Association of Diabetes and Pregnancy Study Groups. Logistic regression was applied to calculate the odds ratios ( ORs) and 95% confidence intervals ( CIs) between ABO blood types and GDM risk.
RESULTS:A total of 30,740 pregnant women with a mean age of 31.81 years were enrolled in this study. The ABO blood types distribution was: type O (30.99%), type A (26.58%), type B (32.20%), and type AB (10.23%). GDM was identified in 14.44% of participants. Using blood type O as a reference, GDM risk was not significantly higher for types A ( OR = 1.05) or B ( OR = 1.04). However, women with type AB had a 19% increased risk of GDM ( OR = 1.19, 95% CI = 1.05-1.34; P < 0.05), even after adjusting for various factors. This increased risk for type AB was consistent across subgroup and sensitivity analyses.
CONCLUSION:The ABO blood types may influence GDM risk, with type AB associated with a higher risk. Incorporating it-either as a single risk factor or in combination with other known factors-could help identify individuals at risk for GDM before or during early pregnancy.
